TY - JOUR
T1 - Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis
AU - Wigg, Alan J.
AU - Wundke, Rachel
AU - McCormick, Rosemary
AU - Muller, Kate R.
AU - Ramachandran, Jeyamani
AU - Narayana, Sumudu K.
AU - Woodman, Richard J.
PY - 2019/5/1
Y1 - 2019/5/1
N2 -
Patients with cirrhosis have increased morbidity from hepatitis A virus (HAV) and hepatitis B virus (HBV) infections, and vaccination against these infections is an important standard of care.
1,2
However, vaccination in patients with cirrhosis is hindered by immune dysfunction and there is limited high-quality literature available. The aim of this work therefore was to compare immune responses of standard dose (SD) with high-dose accelerated (HDA) vaccination in cirrhotic patients.
AB -
Patients with cirrhosis have increased morbidity from hepatitis A virus (HAV) and hepatitis B virus (HBV) infections, and vaccination against these infections is an important standard of care.
1,2
However, vaccination in patients with cirrhosis is hindered by immune dysfunction and there is limited high-quality literature available. The aim of this work therefore was to compare immune responses of standard dose (SD) with high-dose accelerated (HDA) vaccination in cirrhotic patients.
UR - http://www.scopus.com/inward/record.url?scp=85063128756&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2018.08.047
DO - 10.1016/j.cgh.2018.08.047
M3 - Short survey
C2 - 30144521
AN - SCOPUS:85063128756
VL - 17
SP - 1210-1212.e1
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
SN - 1542-3565
IS - 6
ER -